Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for CLPBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2012. Start Trial.
Date Value
May 31, 2026 63.03%
April 30, 2026 62.97%
March 31, 2026 60.31%
February 28, 2026 54.58%
January 31, 2026 50.17%
December 31, 2025 50.17%
November 30, 2025 50.17%
October 31, 2025 50.17%
September 30, 2025 50.17%
August 31, 2025 47.10%
July 31, 2025 47.10%
June 30, 2025 47.10%
May 31, 2025 47.10%
April 30, 2025 47.10%
March 31, 2025 47.10%
February 28, 2025 47.10%
January 31, 2025 47.10%
December 31, 2024 47.10%
November 30, 2024 47.10%
October 31, 2024 47.10%
September 30, 2024 47.10%
August 31, 2024 47.10%
July 31, 2024 47.10%
June 30, 2024 47.10%
May 31, 2024 47.10%
Date Value
April 30, 2024 47.10%
March 31, 2024 47.10%
February 29, 2024 47.10%
January 31, 2024 47.10%
December 31, 2023 47.10%
November 30, 2023 47.10%
October 31, 2023 47.10%
September 30, 2023 47.10%
August 31, 2023 47.10%
July 31, 2023 47.10%
June 30, 2023 53.38%
May 31, 2023 54.00%
April 30, 2023 60.10%
March 31, 2023 61.10%
February 28, 2023 61.15%
January 31, 2023 61.81%
December 31, 2022 62.38%
November 30, 2022 64.06%
October 31, 2022 65.23%
September 30, 2022 65.23%
August 31, 2022 65.23%
July 31, 2022 65.23%
June 30, 2022 65.23%
May 31, 2022 65.23%
April 30, 2022 65.23%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Ambu A/S 86.14%
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%
AtriCure, Inc. 77.21%